Related references
Note: Only part of the references are listed.Methotrexate and rheumatoid arthritis associated interstitial, Lung disease
Pierre-Antoine Juge et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib
Shigeki Makino
MODERN RHEUMATOLOGY (2021)
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease
David Roofeh et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Predictors of Progression and Mortality in Patients with Prevalent Rheumatoid Arthritis and Interstitial Lung Disease: A Prospective Cohort Study
Natalia Mena-Vazquez et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review
Esther F. Vicente-Rabaneda et al.
AUTOIMMUNITY REVIEWS (2021)
Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
Michael P. Mohning et al.
ERJ OPEN RESEARCH (2021)
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial
Tomoyuki Fujisawa et al.
RESPIROLOGY (2021)
Related factors, increased mortality and causes of death in patients with rheumatoid arthritis-associated interstitial lung disease
Takuya Kakutani et al.
MODERN RHEUMATOLOGY (2020)
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study
Andreina Manfredi et al.
INTERNAL MEDICINE JOURNAL (2020)
Impact of radiological honeycombing in rheumatoid arthritis-associated interstitial lung disease
Hideaki Yamakawa et al.
BMC PULMONARY MEDICINE (2020)
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows
Giulia Cassone et al.
JOURNAL OF CLINICAL MEDICINE (2020)
RA-ILD: does more detailed radiological classification add something to our knowledge of this condition?
Paola Faverio et al.
JOURNAL OF THORACIC DISEASE (2020)
The challenges in classifying rheumatoid arthritis -associated interstitial disease
Hanna Nurmi et al.
JOURNAL OF THORACIC DISEASE (2020)
Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease
Charlisa D. Gibson et al.
LUNG (2020)
Rheumatoid Arthritis-Associated Interstitial Lung Disease: Current Update on Prevalence, Risk Factors, and Pharmacologic Treatment
Sicong Huang et al.
CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY (2020)
Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis
Hideto Kameda et al.
MODERN RHEUMATOLOGY (2019)
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis
Christopher R. Holroyd et al.
RHEUMATOLOGY (2019)
Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease
Zhiwei Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?
Ying Huang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population
Qiang Fu et al.
CLINICAL RHEUMATOLOGY (2019)
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Joseph Jacobt et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Telomere length and genetic variant associations with interstitial lung disease progression and survival
Chad A. Newton et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria
Hideaki Yamakawa et al.
JOURNAL OF THORACIC DISEASE (2019)
Methotrexate-Associated Pneumonitis and Rheumatoid Arthritis-Interstitial Lung Disease: Current Concepts for the Diagnosis and Treatment
George E. Fragoulis et al.
FRONTIERS IN MEDICINE (2019)
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases
Ayodeji Adegunsoye et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)
Prognostic factors and disease behaviour of pathologically proven fibrotic non-specific interstitial pneumonia
Hideaki Yamakawa et al.
RESPIROLOGY (2018)
Multidimensional improvement in connective tissue disease-associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus
Yasuhiko Yamano et al.
RESPIROLOGY (2018)
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
Kazuhiro Kurasawa et al.
RHEUMATOLOGY (2018)
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
P. -A. Juge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice
Sophie V. Fletcher et al.
ERJ OPEN RESEARCH (2018)
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
Vincent Cottin et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Patterns of interstitial lung disease and mortality in rheumatoid arthritis
Jorge A. Zamora-Legoff et al.
RHEUMATOLOGY (2017)
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease
Julie Morisset et al.
RESPIRATORY MEDICINE (2017)
High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival
Zulma X. Yunt et al.
RESPIRATORY MEDICINE (2017)
Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease
Jake G. Natalini et al.
RESPIRATORY MEDICINE (2017)
Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease
Jorge A. Zamora-Legoff et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Safety and maintenance of response for tofacitinib monotherapy and combination therapy in rheumatoid arthritis: an analysis of pooled data from open-label long-term extension studies
Roy Fleischmann et al.
RMD OPEN (2017)
The role of high-resolution computed tomography in the follow-up of diffuse lung disease
Brett M. Elicker et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
Joshua J. Solomon et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease
Jorge A. Zamora-Legoff et al.
CLINICAL RHEUMATOLOGY (2016)
Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study
Mitsuhiro Akiyama et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences
Motoki Natsuizaka et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
A Roadmap to Promote Clinical and Translational Research in Rheumatoid Arthritis-Associated Interstitial Lung Disease A Dance Promote Clinical and Translational Research
Tracy J. Doyle et al.
CHEST (2014)
Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA
Kumi Shidara et al.
Modern Rheumatology (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Usual Interstitial Pneumonia Preceding Collagen Vascular Disease: A Retrospective Case Control Study of Patients Initially Diagnosed with Idiopathic Pulmonary Fibrosis
Masato Kono et al.
PLOS ONE (2014)
Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study
Clive A. Kelly et al.
RHEUMATOLOGY (2014)
Analysis of Infections and All-Cause Mortality in Phase II, Phase III, and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis
Stanley Cohen et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia
Teng Moua et al.
RESPIRATORY RESEARCH (2014)
Acute pulmonary injury: high-resolution CT and histopathological spectrum
E. T. Obadina et al.
BRITISH JOURNAL OF RADIOLOGY (2013)
Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies. Clinical, radiological and histopathological clues to aetiology
Maxwell Smith et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study
Hironao Hozumi et al.
BMJ OPEN (2013)
Connective tissue disease-associated interstitial lung disease: a review
Markus Gutsche et al.
CURRENT PULMONOLOGY REPORTS (2012)
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
Takao Koike et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome
Y. Tsuchiya et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Incidence and Mortality of Interstitial Lung Disease in Rheumatoid Arthritis
Tim Bongartz et al.
ARTHRITIS AND RHEUMATISM (2010)
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
E. J. Kim et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort
Gouri Koduri et al.
RHEUMATOLOGY (2010)
Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA
A. Nakajima et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2010)
Update on the diagnosis and treatment of Pneumocystis pneumonia
Eva M. Carmona et al.
Therapeutic Advances in Respiratory Disease (2010)
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Rheumatoid arthritis interstitial lung disease: Mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug
Lcslcy Ann Saketkoo et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: Changes in pattern and distribution of disease over time
C. Isabela S. Silva et al.
RADIOLOGY (2008)
Effects of 1-year treatment with CycNophosphamilde on outcomes at 2 years in scleroderma lung disease
Donald P. Tashkin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Prognosis of fibrotic interstitial pneumonia - Idiopathic versus collagen vascular disease-related subtypes
Joo Hun Park et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Mycophenolate mofetil is safe, well tolerated, and preserves lung function, in patients with connective tissue disease-related interstitial lung disease
Jeffrey J. Swigris et al.
CHEST (2006)
Prognostic factors and causes of death in Korean patients with idiopathic pulmonary fibrosis
K Jeon et al.
RESPIRATORY MEDICINE (2006)
Histopathologic pattern and clinical features of rheumatoid arthritis associated interstitial lung disease
HK Lee et al.
CHEST (2005)
Combined bronchoalveolar lavage and transbronchial lung biopsy:: safety and yield in ventilated patients
PA Bulpa et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis
JK Dawson et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Sulphasalazine and lung toxicity
SD Parry et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Share Paper
